Talis Biomedical Corporation (TLIS)
USD 1.6
(6.67%)
USD 1.6
(6.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -66.81 Million USD | 42.88% |
| 2022 | -115.13 Million USD | 39.97% |
| 2021 | -191.81 Million USD | -110.36% |
| 2020 | -91.18 Million USD | -241.53% |
| 2019 | -26.69 Million USD | -24.59% |
| 2018 | -21.43 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.14 Million USD | 36.92% |
| 2024 Q2 | -8.57 Million USD | -4.72% |
| 2023 Q4 | -14.5 Million USD | 14.56% |
| 2023 FY | -65.77 Million USD | 42.88% |
| 2023 Q1 | -18.99 Million USD | 32.42% |
| 2023 Q2 | -16.39 Million USD | 13.72% |
| 2023 Q3 | -16.97 Million USD | -3.54% |
| 2022 Q2 | -27.27 Million USD | 17.27% |
| 2022 FY | -115.13 Million USD | 39.97% |
| 2022 Q4 | -28.11 Million USD | -4.95% |
| 2022 Q3 | -26.78 Million USD | 1.79% |
| 2022 Q1 | -32.96 Million USD | -15.59% |
| 2021 Q4 | -28.52 Million USD | 25.76% |
| 2021 Q1 | -60.52 Million USD | -36.98% |
| 2021 FY | -191.81 Million USD | -110.36% |
| 2021 Q2 | -64.36 Million USD | -6.35% |
| 2021 Q3 | -38.41 Million USD | 40.31% |
| 2020 Q3 | -29.58 Million USD | -195.12% |
| 2020 FY | -91.18 Million USD | -241.53% |
| 2020 Q4 | -44.18 Million USD | -49.35% |
| 2020 Q2 | -10.02 Million USD | -35.55% |
| 2020 Q1 | -7.39 Million USD | -2.67% |
| 2019 FY | -26.69 Million USD | -24.59% |
| 2019 Q4 | -7.2 Million USD | 0.0% |
| 2018 FY | -21.43 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -365.253% |
| Biotricity, Inc. | -8.82 Million USD | -656.83% |
| Cell MedX Corp. | -313.43 Thousand USD | -21217.36% |
| Dynatronics Corporation | -2.27 Million USD | -2839.445% |
| Nemaura Medical Inc. | -9.59 Million USD | -596.335% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -529.064% |
| RetinalGenix Technologies Inc. | -2.08 Million USD | -3101.41% |
| Sonendo, Inc. | -57.74 Million USD | -15.711% |
| Telesis Bio, Inc. | -35.15 Million USD | -90.085% |
| Viveve Medical, Inc. | -21.55 Million USD | -210.003% |